The purpose of this HHS task order is to procure services for the storage and stability of bulk lots & final containers of-adjuvant( AS03) covid-19 funds.
Active Awarded Last action
- Contract number
- 75A50124F61012
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $14,047,404
Award facts
- Contract value 100% obligated
- $14,047,403.70 Current and potential, with all options
- Completion date 82% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27701, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $8,741,350 | |
| Other Administrative Action | $0 | |
| Original award | $5,306,054 |
About this award
This federal contract award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, is for the storage and stability testing of bulk lots and final containers of COVID-19 vaccine adjuvant (AS03) on behalf of the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response. The $14,047,403.70 firm fixed price delivery order, which has no set-aside designation, has a performance period through May 21, 2027. Glaxosmithkline, a foreign-owned pharmaceutical company with expertise in vaccine development and production, has previously been awarded federal contracts and grants from agencies such as the Departments of Defense, Veterans Affairs, and Centers for Disease Control and Prevention to supply influenza vaccines, antiviral medications, and other pharmaceutical products in support of public health and medical countermeasure initiatives.
Quick answers
Who was awarded contract 75A50124F61012?
75A50124F61012 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on February 21, 2024.
How much is contract 75A50124F61012 worth?
The government has obligated $14,047,404 on 75A50124F61012.
Is contract 75A50124F61012 an order under another contract?
Yes. 75A50124F61012 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50124F61012 competed?
The extent of competition for 75A50124F61012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award